BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17010614)

  • 1. RAMPs: The past, present and future.
    Parameswaran N; Spielman WS
    Trends Biochem Sci; 2006 Nov; 31(11):631-8. PubMed ID: 17010614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs.
    Sexton PM; Morfis M; Tilakaratne N; Hay DL; Udawela M; Christopoulos G; Christopoulos A
    Ann N Y Acad Sci; 2006 Jul; 1070():90-104. PubMed ID: 16888151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating receptor function through RAMPs: can they represent drug targets in themselves?
    Sexton PM; Poyner DR; Simms J; Christopoulos A; Hay DL
    Drug Discov Today; 2009 Apr; 14(7-8):413-9. PubMed ID: 19150656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAMPs: 5 years on, where to now?
    Morfis M; Christopoulos A; Sexton PM
    Trends Pharmacol Sci; 2003 Nov; 24(11):596-601. PubMed ID: 14607083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors.
    Pioszak AA; Hay DL
    Adv Pharmacol; 2020; 88():115-141. PubMed ID: 32416865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor activity-modifying proteins; multifunctional G protein-coupled receptor accessory proteins.
    Hay DL; Walker CS; Gingell JJ; Ladds G; Reynolds CA; Poyner DR
    Biochem Soc Trans; 2016 Apr; 44(2):568-73. PubMed ID: 27068971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing GPCR activation using protein complementation: a novel technique for HTS.
    Eglen RM
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):746-8. PubMed ID: 17635139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The receptor activity modifying protein family of G protein coupled receptor accessory proteins.
    Udawela M; Hay DL; Sexton PM
    Semin Cell Dev Biol; 2004 Jun; 15(3):299-308. PubMed ID: 15125893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor activity modifying proteins and their potential as drug targets.
    Wootten DL; Simms J; Hay DL; Christopoulos A; Sexton PM
    Prog Mol Biol Transl Sci; 2010; 91():53-79. PubMed ID: 20691959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development.
    Archbold JK; Flanagan JU; Watkins HA; Gingell JJ; Hay DL
    Trends Pharmacol Sci; 2011 Oct; 32(10):591-600. PubMed ID: 21722971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clathrin-dependent mechanisms of G protein-coupled receptor endocytosis.
    Wolfe BL; Trejo J
    Traffic; 2007 May; 8(5):462-70. PubMed ID: 17376169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis of the calcitonin receptor-like receptor domains responsible for cell-surface translocation of receptor activity-modifying proteins.
    Kuwasako K; Kitamura K; Nagata S; Kato J
    Biochem Biophys Res Commun; 2009 Jun; 384(2):249-54. PubMed ID: 19394311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural diversity of G protein-coupled receptors and significance for drug discovery.
    Lagerström MC; Schiöth HB
    Nat Rev Drug Discov; 2008 Apr; 7(4):339-57. PubMed ID: 18382464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimerization and negative cooperativity in the relaxin family peptide receptors.
    Svendsen AM; Vrecl M; Knudsen L; Heding A; Wade JD; Bathgate RA; De Meyts P; Nøhr J
    Ann N Y Acad Sci; 2009 Apr; 1160():54-9. PubMed ID: 19416159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accessory proteins in the biogenesis of G protein-coupled receptors.
    Bermak JC; Zhou QY
    Mol Interv; 2001 Dec; 1(5):282-7. PubMed ID: 14993367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of G protein-coupled receptor trafficking.
    Xu ZQ; Zhang X; Scott L
    Acta Physiol (Oxf); 2007 May; 190(1):39-45. PubMed ID: 17428231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics of G protein-coupled receptor signaling: insights from health and disease.
    Thompson MD; Cole DE; Jose PA
    Methods Mol Biol; 2008; 448():77-107. PubMed ID: 18370232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Past, present and future of vasopressin and oxytocin receptor oligomers, prototypical GPCR models to study dimerization processes.
    Cottet M; Albizu L; Perkovska S; Jean-Alphonse F; Rahmeh R; Orcel H; Méjean C; Granier S; Mendre C; Mouillac B; Durroux T
    Curr Opin Pharmacol; 2010 Feb; 10(1):59-66. PubMed ID: 19896898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monomeric G-protein-coupled receptor as a functional unit.
    Chabre M; le Maire M
    Biochemistry; 2005 Jul; 44(27):9395-403. PubMed ID: 15996094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-protein-coupled receptor heterodimerization: assay technologies to clinical significance.
    Kent T; McAlpine C; Sabetnia S; Presland J
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):580-9. PubMed ID: 17786857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.